Pages

Thursday, September 17, 2009

Intestinal Lymphoma in Cats

Lingard AE, Briscoe K, Beatty JA, et al. Low-grade alimentary lymphoma: clinicopathological findings and response to treatment in 17 cases. J Feline Med Surg 2009; 11: 692-700.

Alimentary lymphoma is the most common anatomic form of lymphoma in the cats. Seventeen cats in this study were diagnosed with low-grade alimentary lymphoma (LGAL) by immunological and immunohistochemical evaluation of full-thickness biopsies collected from multiple gastrointestinal sites during exploratory laparotomy. The most common clinical signs were weight loss, inappetence, vomiting or diarrhea, vomiting and diarrhea, lethargy, and polyphagia. Vomiting and/or diarrhea were considered chronic in 11 of 15 cats. Abdominal palpation was abnormal in 12 cats. Mature neutrophilia and anemia were the most common hematological abnormalities. Serum albumin was normal in all cats tested. The most common ultrasonographic finding was normal or increased intestinal wall thickness with preservation of layering. LGAL is typically a diffuse or multifocal disease and the ileum and jejenum were most commonly affected. The cats were put on three chemotherapeutic protocols, the majority being given the oral chemotherapeutic regimen of prednisolone and high-dose pulse chlorambucil. Thirteen of the 17 cats (76%) had complete clinical remission with a median remission time of 18.9 months. Cats that were lethargic were less likely to achieve complete remission. The prognosis for cats with LGAL treated with oral prednisolone in combination with high-dose pulse chlorambucil is good to excellent. [VT]
>> PubMed Abstract

Related articles:
Wilson HM. Feline alimentary lymphoma: demystifying the enigma. Top Companion Anim Med 2008; 23: 177-84.
>> PubMed Abstract

Waly NE, Gruffydd-Jones TJ, Stokes CR, Day MJ. Immunohistochemical diagnosis of alimentary lymphomas and severe intestinal inflammation in cats. J Comp Pathol 2005; 133: 253-60.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Lingard AE, Briscoe K, Beatty JA, et al. Low-grade alimentary lymphoma: clinicopathological findings and response to treatment in 17 cases. J Feline Med Surg 2009; 11: 692-700.

Alimentary lymphoma is the most common anatomic form of lymphoma in the cats. Seventeen cats in this study were diagnosed with low-grade alimentary lymphoma (LGAL) by immunological and immunohistochemical evaluation of full-thickness biopsies collected from multiple gastrointestinal sites during exploratory laparotomy. The most common clinical signs were weight loss, inappetence, vomiting or diarrhea, vomiting and diarrhea, lethargy, and polyphagia. Vomiting and/or diarrhea were considered chronic in 11 of 15 cats. Abdominal palpation was abnormal in 12 cats. Mature neutrophilia and anemia were the most common hematological abnormalities. Serum albumin was normal in all cats tested. The most common ultrasonographic finding was normal or increased intestinal wall thickness with preservation of layering. LGAL is typically a diffuse or multifocal disease and the ileum and jejenum were most commonly affected. The cats were put on three chemotherapeutic protocols, the majority being given the oral chemotherapeutic regimen of prednisolone and high-dose pulse chlorambucil. Thirteen of the 17 cats (76%) had complete clinical remission with a median remission time of 18.9 months. Cats that were lethargic were less likely to achieve complete remission. The prognosis for cats with LGAL treated with oral prednisolone in combination with high-dose pulse chlorambucil is good to excellent. [VT]
>> PubMed Abstract

Related articles:
Wilson HM. Feline alimentary lymphoma: demystifying the enigma. Top Companion Anim Med 2008; 23: 177-84.
>> PubMed Abstract

Waly NE, Gruffydd-Jones TJ, Stokes CR, Day MJ. Immunohistochemical diagnosis of alimentary lymphomas and severe intestinal inflammation in cats. J Comp Pathol 2005; 133: 253-60.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Read More


Monday, September 14, 2009

New Treatment for Feline Herpesvirus

Winn funded research

Wilkes RP, Kania SA. Use of interfering RNAs targeted against feline herpesvirus 1 glycoprotein D for inhibition of feline herpesvirus 1 infection of feline kidney cells. Am J Vet Res 2009; 70: 1018-25.

Feline herpesvirus causes at least 50% of upper respiratory infections in the cat. While vaccines are available, the virus persists in cat populations and spreads readily from infected to naive cats. As well, chronic disease occurs in latently infected cats. Most antiviral medications approved for a similar virus in people are either too toxic for cats or are only minimally effective. Small interfering RNAs (RNAi) are novel therapies that can be used to inhibit expression of genes of interest. This study evaluated the use of RNAi targeted against feline herpesvirus glycoprotein D in order to inhibit herpesvirus infection of cell cultures. Six chemically produced RNAi constructs were evaluated, and two of them proved highly effective in reducing expression of the target glycoprotein. Treatment of cell cultures with RNAi resulted in inhibition of herpesvirus replication. The researchers were able to show that glycoprotein D is essential for the virus to infect cells, and is a potential new target for antiviral treatment. [SL]
>> PubMed Abstract

Related articles:
Thiry E, Addie D, Belak S, et al. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 547-55.
>> Free, full text article

Malik R, Lessels NS, Webb S, et al. Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs. Journal of Feline Medicine & Surgery 2009; 11: 40-48.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Winn funded research

Wilkes RP, Kania SA. Use of interfering RNAs targeted against feline herpesvirus 1 glycoprotein D for inhibition of feline herpesvirus 1 infection of feline kidney cells. Am J Vet Res 2009; 70: 1018-25.

Feline herpesvirus causes at least 50% of upper respiratory infections in the cat. While vaccines are available, the virus persists in cat populations and spreads readily from infected to naive cats. As well, chronic disease occurs in latently infected cats. Most antiviral medications approved for a similar virus in people are either too toxic for cats or are only minimally effective. Small interfering RNAs (RNAi) are novel therapies that can be used to inhibit expression of genes of interest. This study evaluated the use of RNAi targeted against feline herpesvirus glycoprotein D in order to inhibit herpesvirus infection of cell cultures. Six chemically produced RNAi constructs were evaluated, and two of them proved highly effective in reducing expression of the target glycoprotein. Treatment of cell cultures with RNAi resulted in inhibition of herpesvirus replication. The researchers were able to show that glycoprotein D is essential for the virus to infect cells, and is a potential new target for antiviral treatment. [SL]
>> PubMed Abstract

Related articles:
Thiry E, Addie D, Belak S, et al. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 547-55.
>> Free, full text article

Malik R, Lessels NS, Webb S, et al. Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs. Journal of Feline Medicine & Surgery 2009; 11: 40-48.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Read More